Treating Lymphoma with Bispecific Antibodies Webinar

Featuring

Jennifer Crombie, MD
Medical Oncologist
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School

Lorenzo Falchi, MD
Medical Oncologist
Memorial Sloan Kettering Cancer Center
Assistant Professor
Weill Cornell Graduate School of Medical Sciences

Program Overview

• Overview and Understanding Bispecific Antibody Therapy
• When to Consider Bispecific Antibody Therapy as a Treatment Option for Lymphoma
• Clinical Trials for Bispecific Antibody Therapy
• Managing Potential Treatment Side Effects and the Role of the Caregiver
• Follow-Up Care: What to Expect
• Questions and Answers Session